We are delighted to have advised on the sale of FibroFind to Vespa Capital
FibroFind is a globally recognised, award-winning pre-clinical contract research organisation (CRO) which has revolutionised drug testing and pre-clinical research in human tissue testing. FibroFind’s management team offers world-leading expertise in their field to blue-chip clients across the globe.
FibroFind appointed our Corporate Finance team to assist in finding a strategic partner and support its growth ambitions.
Our experience in the Life Sciences and Pharma industry enabled us to provide specialised sector expertise and insight to support a highly complex business founded on globally renowned capabilities.
Our Corporate Finance team ran a competitive process, garnering interest from both trade and private equity to deliver the best possible outcome for our client as they sought to gain a strategic partner for the next phase of their impressive growth journey.
We provided hands-on support throughout the transaction, managing various deal streams and shareholder interests to produce an excellent outcome for all involved.